News About: Goverment
400 Million Won of Government Grant Available for HACCP System Requestors
In an effort to promote an industry-wide implementation of the Hazard Analysis and Critical Control Point (HACCP) system, the Korea Food and Drug Administration (KFDA) will make available of its 400 million won budget...
Government Ensues Current and Future Efforts in Anti-Smoking Programs
The government plans to make an official announcement on December 30th detailing the revised regulation supporting the public health promotion and improvement.
The existing liability payment for public health promo...
Mandatory Recall System Will Become Effective Next Year
The Ministry of Health and Welfare (MOHW) announced an implementation of mandatory recall system regulation as applied to the pharmaceutical products, which will be effective during the first half of Year 2005.
The...
KFDA Posts Results of Re-Evaluation Reviews on 4,253 Antibiotic Agents
The Korea Food and Drug Administration announced the results of its re-evaluation reviews on 4,253 antibiotic agents from 9 therapeutic areas, on December 23rd.
The results of the KFDA’s re-evaluation reviews were ...
Domestic Guidance on Celecoxib, Naproxen Released
The Korea Food and Drug Administration (KFDA) released its pharmaceutical safety memorandum addressed to the healthcare professionals and to the general public, citing its current effort in reviewing the safety issues...
Increasing Number of Biopharmaceutical Products Qualified with National Standards
A total number of biopharmaceutical products that are qualified under the national standards has now increased to 13 items, according to a recent announcement by the Korea Food and Drug Administration (KFDA).
A n...
One-Call, Total-Service Based KFDA Call Center Now Operational
The Korea Food and Drug Administration has recently announced its launching of the total service call center, effective December 23rd, in order to realize a higher level of efficiency in dealing with over 200,000 civi...
KFDA Takes Detailed Safety Review on Celebrex
The Korea Food and Drug Administration (KFDA) announced that it is taking a detailed safety review on Pfizer’s Celebrex, reflecting the U.S. Food and Drug Administration (FDA)’s recent citation on the safety issues of...
Significant Pharmacy Retail Prices for OTC Products Discovered
The Ministry of Health and Welfare (MOHW) conducted a study of retail price comparisons and differences on 48 pharmaceutical OTC products that are classified as the most frequently purchased items by the consumers, an...
KFDA Announces Implementation of Graded KGMP Management System For Pharmaceutical Manufacturers
The Korea Food and Drug Administration (KFDA) announced its plan to implement a graded management system for the pharmaceutical manufacturers that are Korea Good Manufacturing Practice (KGMP) certified, with an antici...
